Boston Scientific bets on cardiac wearables with $925M Preventice buy

Boston Scientific bets on cardiac wearables with $925M Preventice buy

Source: 
Medtech Dive
snippet: 

Boston Scientific announced Thursday it will purchase cardiac monitoring company Preventice Solutions in a $925 million deal, putting it directly into the fast-growing cardiac monitoring industry. The deal, the second in the space this week, is expected to close by mid-2021.